Testing a new insulin pump algorithm for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 70 years old.
- You have had type 1 diabetes for at least 6 months (or 3 months if you are 2–7 years old).
- You currently take insulin through injections or a pump.
- You are willing to use a specific type of insulin (like Humalog or Novorapid).
- You are comfortable wearing the study devices continuously.
- You can read and understand English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery system (a pump that helps manage blood sugar) in children and adults with diabetes. It aims to see if the system is safe and easy to use in daily life.
This study tests a new hybrid closed-loop system (an automated insulin pump) in people with type 1 diabetes whose blood sugar is not well controlled. It aims to see if the system is safe and helps improve glucose levels.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests whether starting automated insulin delivery (a system that adjusts insulin automatically) early after diagnosis helps children and teens with type 1 diabetes manage their blood sugar better. It also looks at long-term health and costs.
This study follows people with type 1 diabetes who are using the Omnipod 5 insulin pump. The goal is to understand how well the system works in everyday life by collecting data from your pump, continuous glucose monitor, and occasional home blood tests over one year.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.